Mónica Rodríguez de la Vega

Mónica Rodríguez de la Vega

Auto-generated profile, based on publicly available information

Mónica Rodríguez de la Vega

Institute of Biotechnology and Biomedicine, Universitat Autònoma de Barcelona, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2007 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
MVMonica Rodriguez Dela Vega
Monica Rodriguez Dela Vega
RSRafael G. Sevilla
Rafael G. Sevilla
AHAntoni Hermoso
Antoni Hermoso
JLJulia Lorenzo
Julia Lorenzo
Sebastian TancoSebastian Tanco
Sebastian Tanco
Francesc Xavier AvilesFrancesc Xavier Aviles
Francesc Xavier Aviles
Nnal has some sequence similarity to metallocarboxypeptidases, but the biochemical characterization of Nnal has not previously been reported. In this work we performed a detailed genomic scan and found >100 Nnal homologues in bacteria, Protista, and Anima‐lia, including several paralogs in most eukaryotic species. Phylogenetic analysis of the Nnal‐like sequences demonstrates a major divergence between Nnal‐like peptidases and the previously known metallocarboxypeptidases subfamilies: M14A, M14B, and M14C. Conformational mod‐eling of representative Nnal‐like proteins from a variety of species indicates an unusually open active site, a property that might facilitate its action on a wide variety of peptide and protein substrates. To test this, we expressed a recombinant form of one of the Nnal‐like peptidases from Caenσrhabditis elegans and demonstrated that this protein is a fully functional metaUocarboxypeptidase that cleaves a range of C‐terminal amino acids from synthetic peptides. The enzymatic activity is activated by ATP/ADP and salt‐inactivated, and is preferentially inhibited by Z‐Glu‐Tyr dipeptide, which is without precedent in metallocarboxypeptidases and resembles tubulin carboxypeptidase functioning; this hypothesis is strongly reinforced by the results depicted in Kalinina et al. published as accompanying paper in this journal (1). Our findings demonstrate that the M14 family of metallocarboxypeptidases is more complex and diverse than expected, and that Nnal‐like peptidases are functional variants of such enzymes, representing a novel subfamily (we propose the name M14D) that contributes substantially to such diversity.—Rodriguez de la Vega, M., Sevilla, R. G., Hermoso, A., Lorenzo, J., Tanco, S., Diez, A., Fricker, L. D., Bautista, J. M., Avilés, F. X. Nna1‐like proteins are active metallocarboxypeptidases of a new and diverse M14 subfamily. FASEB J. 20, 851–865 (2007)

31 October 2005 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
ABAlex Bayés
Alex Bayés
MCMireia Comellas-Bigler
Mireia Comellas-Bigler
MVMonica Rodríguez de la Vega
Monica Rodríguez de la Vega
KMKlaus Maskos
Klaus Maskos
WBWolfram Bode
Wolfram Bode
JVJosep Vendrell
Josep Vendrell
Corn earworm (Helicoverpa zea), also called tomato fruitworm, is a common pest of many Solanaceous plants. This insect is known to adapt to the ingestion of plant serine protease inhibitors by using digestive proteases that are insensitive to inhibition. We have now identified a B-type carboxypeptidase ofH. zea(CPBHz) insensitive to potato carboxypeptidase inhibitor (PCI) in corn earworm. To elucidate the structural features leading to the adaptation of the insect enzyme, the crystal structure of the recombinant CPBHz protein was determined by x-ray diffraction. CPBHz is a member of the A/B subfamily of metallocarboxypeptidases, which displays the characteristic metallocarboxypeptidase α/β-hydrolase fold, and does not differ essentially from the previously describedHelicoverpa armigeraCPA, which is very sensitive to PCI. The data provide structural insight into several functional properties of CPBHz. The high selectivity shown by CPBHz for C-terminal lysine residues is due to residue changes in the S1′ substrate specificity pocket that render it unable to accommodate the side chain of an arginine. The insensitivity of CPBHz to plant inhibitors is explained by the exceptional positioning of two of the main regions that stabilize other carboxypeptidase–PCI complexes, the β8-α9 loop, and α7 together with the α7-α8 loop. The rearrangement of these two regions leads to a displacement of the active-site entrance that impairs the proper interaction with PCI. This report explains a crystal structure of an insect protease and its adaptation to defensive plant protease inhibitors.

19 October 2012 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
MOMónica Rodríguez de la Vega Otazo
Mónica Rodríguez de la Vega Otazo
JLJulia Lorenzo
Julia Lorenzo
OTOlivia Tort
Olivia Tort
Francesc Xavier AvilesFrancesc Xavier Aviles
Francesc Xavier Aviles
JBJosé M. Bautista
José M. Bautista
Recent experimental data indicating axonal regeneration, axogenesis, dendritogenesis, and ciliary axoneme assembly and wellness have linked the role of cytosolic metallocarboxypeptidase 1 (CCP1/AGTPBP1/Nna1) to the microtubule network. In addition, 5 of the 6 mammalian ccp genes have been shown to participate in post‐translational modifications of tubulin, which occur in the microtubules of neurons, mitotic spindles, cilia, and basal bodies. Here, we compile evidence for the idea that the occurrence of CCPs strongly correlates with the presence of cilia, suggesting that CCP functions might be primarily related to cilia and basal bodies (CBBs). In agreement with this hypothesis, CCPs were localized in centrioles, basal bodies, and mitotic spindles in HeLa cells by confocal microscopy. By reconstructing the evolutionary history of CCPs, we show their presence in the last eukaryotic common ancestor and relate each group of CCP orthologs to specific roles in CBBs. The clues presented in this study suggest that during the evolution of eukaryotes, mechanisms mediated by CCPs through tubulin post‐translational modifications controlling assembly, trafficking, and signaling in the microtubules, were transferred from cilia to cell and axon microtubules.—Rodríguez de la Vega Otazo, M., Lorenzo, J., Tort, O., Avilés, F. X., Bautista, J. M. Functional segregation and emerging role of cilia‐related cytosolic carboxypeptidases (CCPs). FASEB J. 27, 424–431 (2013). www.fasebj.org

1 August 2006 in Insect Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
ABAlex Bayés
Alex Bayés
MVMónica Rodríguez de la Vega
Mónica Rodríguez de la Vega
JVJosep Vendrell
Josep Vendrell
Francesc Xavier AvilesFrancesc Xavier Aviles
Francesc Xavier Aviles
MJMaarten Jongsma
Maarten Jongsma
JBJules Beekwilder
Jules Beekwilder

1 May 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
MRMaday Alonso del Rivero
Maday Alonso del Rivero
STSebastian A. Trejo
Sebastian A. Trejo
MRMey L. Reytor
Mey L. Reytor
MRMonica Rodriguez-De-La-Vega
Monica Rodriguez-De-La-Vega
JDJulieta Delfin
Julieta Delfin
Francesc Xavier AvilesFrancesc Xavier Aviles
Francesc Xavier Aviles
This study describes a novel bifunctional metallocarboxypeptidase and serine protease inhibitor (SmCI) isolated from the tentacle crown of the annelid Sabellastarte magnifica. SmCI is a 165-residue glycoprotein with a molecular mass of 19.69 kDa (mass spectrometry) and 18 cysteine residues forming nine disulfide bonds. Its cDNA was cloned and sequenced by RT-PCR and nested PCR using degenerated oligonucleotides. Employing this information along with data derived from automatic Edman degradation of peptide fragments, the SmCI sequence was fully characterized, indicating the presence of three bovine pancreatic trypsin inhibitor/Kunitz domains and its high homology with other Kunitz serine protease inhibitors. Enzyme kinetics and structural analyses revealed SmCI to be an inhibitor of human and bovine pancreatic metallocarboxypeptidases of the A-type (but not B-type), with nanomolar K(i) values. SmCI is also capable of inhibiting bovine pancreatic trypsin, chymotrypsin, and porcine pancreatic elastase in varying measures. When the inhibitor and its nonglycosylated form (SmCI N23A mutant) were overproduced recombinantly in a Pichia pastoris system, they displayed the dual inhibitory properties of the natural form. Similarly, two bi-domain forms of the inhibitor (recombinant rSmCI D1-D2 and rSmCI D2-D3) as well as its C-terminal domain (rSmCI-D3) were also overproduced. Of these fragments, only the rSmCI D1-D2 bi-domain retained inhibition of metallocarboxypeptidase A but only partially, indicating that the whole tri-domain structure is required for such capability in full. SmCI is the first proteinaceous inhibitor of metallocarboxypeptidases able to act as well on another mechanistic class of proteases (serine-type) and is the first of this kind identified in nature.

29 May 2012 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
AOAnabel Otero
Anabel Otero
MVMónica Rodríguez de la Vega
Mónica Rodríguez de la Vega
Sebastian TancoSebastian Tanco
Sebastian Tanco
JLJulia Lorenzo
Julia Lorenzo
Francesc Xavier AvilesFrancesc Xavier Aviles
Francesc Xavier Aviles
DRDavid Reverter
David Reverter
PaCCP is a metallocarboxypeptidase (MCP) of the M14 family from Pseudomonas aeruginosa , which belongs to a bacterial clade of carboxypeptidases that are homologous to the recently discovered M14D subfamily of human nonsecretory cytosolic carboxypeptidases (CCPs). CCPs are intracellular peptidases involved, among other roles, in the post‐translational modifications of tubulin. Here we report the crystal structure of PaCCP at high resolution (1.6 Å). Its 375 residues are folded in a novel β‐sandwich N‐terminal domain followed by the classical carboxypeptidase α/β‐hydrolase domain, this one in a shorter and more compact form. The former is unique in the whole family and does not have sequential or structural homology with other domains that are usually flanking the latter, like the prodomain of the M14A subfamily or the C‐terminal transthyretin/prealbumin‐like domains of the M14B subfamily. PaCCP does not display activity against small carboxypeptidase substrates, so in this form it might constitute an inactive precursor of the protease. Structural results derived from cocrystallization with well‐known inhibitors of MCPs indicate that the enzyme might only possess C‐terminal hydrolase activity against cellular substrates of particular specificity and/or when undergoes structural rearrangements. The derived PaCCP structure allows a first structural insight into the more complex and largely unknown mammalian CCP subfamily.—Otero, A., Rodríguez de la Vega, M., Tanco, S., Lorenzo, J., Avilés, F. X., Reverter, D. The novel structure of a cytosolic M14 metallocarboxypeptidase (CCP) from Pseudomonas aeruginosa : a model for mammalian CCPs. FASEB J. 26, 3754–3764 (2012). www.fasebj.org